Pappas Capital appoints Mathers as partner
Pappas Capital, which invests in the life sciences sector, has named Thomas Mathers as a partner. Previously, Mathers was CEO of CoLucid Pharmaceuticals, which is backed by Pappas Capital.
10 April 2018•3 mins read
